Antagonistic pleiotropy: the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age

Mahmoud Abdellatif; Frank Madeo; Simon Sedej; Guido Kroemer

doi:10.1080/14728222.2023.2178420

Antagonistic pleiotropy: the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age

Mahmoud Abdellatif, Frank Madeo, Simon Sedej, Guido Kroemer

Résultats de recherche: Contribution à un journal › Editorial

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	87-90
Nombre de pages	4
journal	Expert Opinion on Therapeutic Targets
Volume	27
Numéro de publication	2
Les DOIs	https://doi.org/10.1080/14728222.2023.2178420
état	Publié - 1 janv. 2023

Accès au document

10.1080/14728222.2023.2178420

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{0a939f3196304e1dbdcb11a15665d0b4,

title = "Antagonistic pleiotropy: the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age",

keywords = "Aging, healthspan, heart, IGF-1, insulin, longevity",

author = "Mahmoud Abdellatif and Frank Madeo and Simon Sedej and Guido Kroemer",

year = "2023",

month = jan,

day = "1",

doi = "10.1080/14728222.2023.2178420",

language = "English",

volume = "27",

pages = "87--90",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

number = "2",

}

TY - JOUR

T1 - Antagonistic pleiotropy

T2 - the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age

AU - Abdellatif, Mahmoud

AU - Madeo, Frank

AU - Sedej, Simon

AU - Kroemer, Guido

PY - 2023/1/1

Y1 - 2023/1/1

KW - Aging

KW - healthspan

KW - heart

KW - IGF-1

KW - insulin

KW - longevity

UR - http://www.scopus.com/inward/record.url?scp=85148455605&partnerID=8YFLogxK

U2 - 10.1080/14728222.2023.2178420

DO - 10.1080/14728222.2023.2178420

M3 - Editorial

C2 - 36749698

AN - SCOPUS:85148455605

SN - 1472-8222

VL - 27

SP - 87

EP - 90

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

IS - 2

ER -